1. Introduction {#sec0005}
===============

Pavlovian trace conditioning procedures require the acquisition of an association between a conditioned stimulus (CS, e.g. noise) and an unconditioned stimulus (US, e.g. food or foot shock) despite the interposition of an interval of time between these events ([@bib0150]). The ability to condition to the trace of the CS when it is no longer present allows animals to form associations when events, which may nonetheless be causally-related, are separated in time. By definition, trace conditioning procedures test working memory defined as the capacity to maintain 'on line' transitory information ([@bib0065]). Such working memory is likely essential for associative processes in general, and in particular when a time interval must be bridged ([@bib0060]). Hence trace conditioning is widely used to investigate the neural substrates of this important aspect of working memory ([@bib0020]).

The dominant paradigm used to study trace conditioning is eye blink conditioning in the rabbit which is known to rely on interactions between medial pre-frontal cortex (mPFC) and cerebellum ([@bib0105]). Cerebellum may not be necessary for trace conditioning in other task variants and in any case it is important to test the generality of findings. Moreover, eye blink procedures typically use a very short trace or inter-stimulus-interval (ISI). We have therefore developed task variants suitable to examine trace conditioning over longer ISIs than the ms intervals typical of eye blink conditioning procedures.

In an appetitively motivated procedure, we have previously reported that systemic treatment with the dopamine (DA) D1 receptor agonist SKF81297 (0.4 and 0.8 mg/kg) depressed acquisition at a 2-s inter-stimulus-interval (ISI), suitable to detect trace conditioning impairment ([@bib0165]). There was no effect on trace conditioning over the 10-s interval which was included to test for trace conditioning enhancement. This finding was counter to expectation in that systemic amphetamines reliably increase conditioning over a trace interval ([@bib0085], [@bib0140]). One possibility is that the motivation of the trace conditioning variant in use is an important determinant of the profile of dopaminergic modulation.

The conditioned emotional response (CER: noise → foot shock) procedures used in the present study are well established ([@bib0010]; [@bib0025]; [@bib0080]; [@bib0085]; [@bib0135]; [@bib0140]). These same procedures are sensitive to the effects of indirect DA agonists (systemically administered amphetamines: [@bib0085], [@bib0140]), as well as catecholaminergic depletion in nucleus accumbens ([@bib0135]). Dopaminergic mechanisms are clearly involved in both appetitive ([@bib0035]) and aversive conditioning ([@bib0045]; [@bib0110]; [@bib0160]; [@bib0155]). However, comparing across appetitive and aversive trace conditioning variants, there is evidence pointing to some differences in the underlying mechanisms ([@bib0010]).

Motivational valence inevitably affects other procedural parameters in that foot shock is more salient than food reward and salience is an important determinant of associative leaning. Many more learning trials are used in appetitive than is necessary or desirable in aversive procedures. In itself, the number of learning trials may also be a critical parameter in that a higher number of learning trials affords additional opportunity for consolidation, as well as an extended period of consolidation to the extent the duration of the conditioning session is increased along with the number of trials ([@bib0030]; [@bib0040]; [@bib0055]; [@bib0115]). In CER procedures conducted at lower foot shock intensities, a greater number of pairings may result in a comparable level of conditioning to that typically seen after two pairings at higher foot shock intensity ([@bib0140]). Therefore, in the present study, we also used an increased numbers of pairings to promote consolidation, at a lower foot shock intensity to match -- as far as possible -- the baseline level of conditioned fear. Specifically, we compared the effects of SKF81297 (0.4 and 0.8 mg/kg) on trace conditioning conducted in a CER procedure using two (Experiment 1) or four (Experiment 2) pairings of a noise CS with foot shock, set at 1 mA (Experiment 1) or 0.5 mA (Experiment 2). In both experiments, we examined the effects of SKF81297 at 3-s and 30-s trace intervals which are suitable to test for impaired and enhanced trace CER conditioning, respectively. Thus we sought to examine the generality of the previous finding of impaired (short) trace conditioning obtained with SKF81297 in an appetitive procedure ([@bib0165]) while including a longer trace suitable to test for trace conditioning enhancement ([@bib0085], [@bib0140]). Finally, the drug naïve (vehicle-injected) rats tested in Experiment 2 were subsequently used to examine the effects of the same doses of SKF81297 on locomotor activity (LMA) by way of positive control.

2. Materials and methods {#sec0010}
========================

2.1. Subjects {#sec0015}
-------------

Seventy-two experimentally naïve adult male Wistar rats (Charles River, UK) were used for each experiment. They were caged in groups of four, in individually ventilated cages (IVCs) on a 12:12 h light/dark cycle with food and water ad libitum. After arrival, each rat was handled daily for one week and placed on water restriction 24 h prior to the start of each experiment. The mean start weight was 220 g (range 196--239 g) in Experiment 1 and 212 g (range 191--246 g) in Experiment 2. All procedures were conducted in accordance with the UK Animal Scientific Procedures Act 1986, Project Licence numbers: PPL 40/3163 (Experiment 1) and PPL 40/3716 (Experiment 2).

2.2. Drug treatments {#sec0020}
--------------------

SKF81297 (Tocris, UK) was dissolved in saline (0.9% NaCl) to provide an injectable volume of 1 ml/kg at doses of 0.4 mg/kg and 0.8 mg/kg. Drug doses were based on previous studies run in our laboratory ([@bib0130]; [@bib0165]). In both experiments, vehicle (saline) or SKF81297 (0.4 mg/kg or 0.8 mg/kg) were injected subcutaneously (s.c.) 15 min prior to the conditioning stage of the trace conditioning procedure. The same treatments were further examined in LMA.

2.3. Trace conditioning apparatus {#sec0025}
---------------------------------

Both experiments were conducted using 6 duplicate fully automated conditioning chambers (Cambridge Cognition, Cambridge, UK), housed within sound-attenuating cases fitted with ventilation fans. The conditioning boxes were made of plain steel (25 cm × 25 cm × 22 cm high) with a Plexiglas door (19 cm × 27 cm) inset at the front. A waterspout was mounted on one wall, 5 cm above the floor and connected to a lickometer supplied by a pump. The number of licks made was registered by a break in the photo beam within the waterspout, which also triggered the delivery of water (0.05 ml per lick). The waterspout was illuminated when water was available. A loudspeaker set in the roof of each conditioning box produced the CS (tone), which consisted of a 5-s mixed frequency noise set at 85 dB (including background); this was presented at either 3-s or 30-s trace intervals before the US (foot shock). The foot shock of 1 s duration set at 1 mA (Experiment 1) or 0.5 mA intensity (Experiment 2) provided the US. This shock was delivered through the grid floor (steel bars 1 cm apart) by a constant current shock generator (pulsed voltage: output square wave 10 ms on, 80 ms off, 370 V peak under no load conditions; MISAC Systems, Newbury, UK). Three wall-mounted stimulus lights and the house light were set to flash on (0.5 s) and off (0.5 s) for the duration of the conditioning session, thus providing an experimental background stimulus. Stimulus control and data collection were performed by an Acorn Archimedes RISC computer programme in Basic with additional interfacing using an Arachnid extension (Cambridge Cognition).

2.4. LMA apparatus {#sec0030}
------------------

Twelve clear Perspex chambers (39.5 cm long × 23.5 cm wide × 24.5 cm deep) with metal grid lids were used (Photobeam Activity System, San Diego Instruments, USA). The chambers were surrounded by frames containing two levels of photobeams as described previously ([@bib0100]; [@bib0180]; [@bib0175]). Two consecutive breaks of adjacent beams within the lower level of photobeams generated a locomotor count. The apparatus was situated in a dimly lit (50-70 lx) room. To start a session, rats were placed into the centre of the chamber. Total locomotor counts were recorded for each consecutive 10-min epoch, for 30 min pre-treatment and 60 min post-treatment.

2.5. Behavioural conditioning procedure {#sec0035}
---------------------------------------

Water restriction was introduced 1 day prior to shaping. The rats received 1 h ad libitum access to water in their home cages after each of the procedural stages described below. This home cage access was in addition to any water drunk in the conditioning boxes (available from the apparatus waterspout on all days of the procedure apart from the conditioning day). Therefore the rats were trained, conditioned and tested in counterbalanced groups of six after 20--23 h of water restriction.

### 2.5.1. Pre-conditioning to establish baseline lick response {#sec0040}

In order to initiate licking behaviour, rats were shaped over two days. On the first day, rats were placed in the conditioning boxes in pairs (with their cage mates), where they were given one or more 15-min sessions to learn how to drink from the illuminated waterspout. On the second day of shaping, they were individually allocated to a conditioning box to ensure that all rats were independently drinking freely. Thereafter, the rats were assigned to their individual boxes for the duration of the experiment (counterbalanced by experimental group). No data were recorded.

Five days of pre-training followed, in which rats drank for 15 min each day (timed from first lick). The waterspout was illuminated throughout, but no other stimuli were present in this phase. The latency to first lick was measured as an indicator of habituation to the experimental context. In addition the total number of licks was also analysed to assess any pre-existing differences in baseline drinking (prior to conditioning).

### 2.5.2. Conditioning with foot shock {#sec0045}

The waterspouts were not illuminated and no water was available during the conditioning session. The US (foot shock) was delivered following the termination of the CS (tone) at either 3-s or 30-s trace intervals. There were two pairings of CS and US in Experiment 1 and four pairings of CS and US in Experiment 2. The flashing light experimental background stimulus was presented for the duration of the conditioning session. In Experiment 1, the first pairing of CS and US was presented after 5 min had elapsed, and the second pairing was 5 min after the first, followed by a further 5 min spent in the apparatus. The same procedure was used in Experiment 2 with two additional CS and US pairings (totalling four). The first pairing was presented after 5 min had elapsed, with the following three pairings presented at 5-min intervals followed by a further 5 min spent in the apparatus. In the absence of licking, no behavioural measures were recorded.

### 2.5.3. Re-shaping after foot shock {#sec0050}

In order to re-establish drinking behaviour after conditioning, rats were re-shaped the following day. This followed the same procedure used in the pre-conditioning, in which rats drank for 15 min (timed from first lick). Conditioning to the box context was measured as the latency to first lick, as well as the profile of drinking over the 15 min session.

### 2.5.4. Test {#sec0055}

Conditioned suppression to the experimental stimuli was tested on two consecutive days following re-shaping. Rats were placed in the conditioning boxes and presented with the CS (tone) on day 1 and the background stimulus (light) on day 2. Water was available throughout the test and the waterspout was illuminated. After the rats had made 50 licks, the stimulus tone (day 1) or light (day 2) was presented for 15 min. The time taken to make the first 50 licks in the absence of any stimulus (the A period) provided a measure of any individual variation in baseline lick responding. This was compared with the time taken to complete 50 licks following stimulus onset (the B period) in a suppression ratio (A/(A + B)) to determine the level of conditioning to either stimulus, adjusted for any individual baseline variation. The profile of drinking over the 15 min session provided an additional measure of conditioned suppression.

2.6. LMA procedure {#sec0060}
------------------

This was tested two replications, each of 12 rats from the vehicle-injected group of Experiment 2. Due to the malfunction of one of the activity chambers, data from two of the available rats was not collected. One day before the drug tests, each rat was placed in a test chamber for 30 min to habituate it to the box. The habituation activity data were also used to match the rats' allocation to drug groups (so that there were no differences in baseline activity). On the following day, rats were replaced in the same test chamber for 30 min to achieve further habituation and to facilitate the detection of any SKF81297-induced LMA. Rats were then subcutaneously injected with saline, or 0.4 or 0.8 mg/kg of SKF81297 and immediately replaced in their allocated activity boxes for 60 min.

2.7. Experimental design and analysis {#sec0065}
-------------------------------------

In both experiments, there were six experimental groups run in a 2 × 3 independent factorial design. The between subject factors were trace at levels 3 s or 30 s and drug at doses saline or SKF81297 (0.4 mg/kg or 0.8 mg/kg). The dependent variables to check for differences by experimental condition-to-be were pre-conditioning drink latencies and the number of licks made during the 15-min pre-conditioning session. Contextual conditioning to the box cues was measured by the reshaping drink latencies and the number of licks made during the 15-min reshaping session. On each of the test days, the level of conditioning to the CS or the experimental background stimulus was measured by the suppression ratios and the number of licks made during the 15-min test session. The licks analyses were run in a mixed design with the repeated measures factor of min which had 15 levels. In the case of significant interactions with min, follow up ANOVA was restricted to the first 60 s of drinking (min 1) which typically shows the closest correspondence with the pattern of effects shown on the suppression ratios at relatively low levels of suppression. [Figs. 1](#fig0005){ref-type="fig"} and 2 show suppression ratios and min 1 licks for the noise tests of both experiments, to allow direct comparison. The locomotor effects of SKF81297 were tested in mixed design with drug as the between-subjects factor and 10 min blocks of activity counts as the within-subjects factor. Follow up ANOVAs by individual block were conducted to explore the interaction. Where required, post hoc tests were performed by Fisher's LSD test.

In Experiment 1, the data of ten rats were excluded from the light test analyses, because of equipment failure on the light test day. This left a final sample size of 62 (n = 9-12/cell). Three rats' data were excluded in Experiment 2, due to equipment failure on the noise test day. This left a final sample size of 69 (n = 10-12/cell). Two rats' data were missing from the LMA analyses, leaving a final sample size of 22 (n = 7-8/cell).

3. Results {#sec0070}
==========

3.1. Experiments 1 with 2 conditioning trials {#sec0075}
---------------------------------------------

### 3.1.1. Pre-conditioning---baseline licking {#sec0080}

There were no effects of drug, F(2,66) = 1.968, p = 0.148, or trace condition-to-be, F \< 1, on the latency to start drinking on the final pre-conditioning day. This confirms that the rats' drinking was well-matched prior to any conditioning. An ANOVA performed on the number of licks made over the 15-min session showed the expected main effect of min, F(14,924) = 109.126, p \< 0.0001. However, the decline in drinking over the course of the session was uninfluenced by drug, F(28,924) = 1.175, p = 0.244, or trace condition-to-be, F(14,924) = 1.189, p = 0.278 (data not shown).

### 3.1.2. Reshaping---contextual conditioning {#sec0085}

On the reshaping day there was no statistical evidence for any effect of prior drug or trace condition on the level of drinking at the start of the session ([Fig. 1](#fig0005){ref-type="fig"}A). There was no difference in the latency to first drink by drug or trace, nor any interaction between these factors, all Fs \<1. There was a main effect of min on the number of licks made over the 15 min session, F(14,924) = 72.639, p \< 0.0001. However, there was no effect of drug by min, F(28,924) = 0.633, p = 0.931, or trace by min, F(14,924) = 1.225, p = 0.251 ([Table 1](#tbl0005){ref-type="table"}A). There was some suggestion that drug treatment at conditioning had some influence on contextual conditioning in that there was a min × drug × trace interaction, F(28,924) = 1.613, p = 0.024, but there was no effect by drug on the min 1 measure, both Fs \< 1.

### 3.1.3. CER test---noise CS {#sec0090}

There was a main effect of trace on the suppression ratio measure, F(1,66) = 35.099, p \< 0.0001, because licking behaviour in rats conditioned with a 30-s trace was less suppressed than licking behaviour in rats conditioned with a 3-s trace interval ([Fig. 1](#fig0005){ref-type="fig"}B). There was no effect of drug, F(2,66) = 2.228, p = 0.116, or of the trace × drug interaction, F \< 1. There was a main effect of min on the number of licks, F(14,924) = 21.758, p \< 0.0001, and, more importantly, an interaction between min and trace, F(14,924) = 7.648, p \< 0.0001. Drug was significant only by min in the linear trend, F(2,66) = 3.646, p = 0.031. Once rats were drinking freely, those which had been treated with 0.8 mg/kg SKF81297 showed the steepest drop in drinking over the session ([Table 1](#tbl0005){ref-type="table"}B). However, there was no effect by drug on the min 1 measure, maximum, F(2,66) = 1.166, p = 0.318. Just as would be expected, there was a main effect of trace, F(1,66) = 33.724, p \< 0.001 ([Fig. 1](#fig0005){ref-type="fig"}C).

### 3.1.4. CER test---flashing lights background {#sec0095}

There was no difference in the suppression ratio scores by trace or drug condition, and there was no interaction between drug and trace, all Fs \<1 ([Fig. 1](#fig0005){ref-type="fig"}D). On the licks measure there was a main effect of min, F(14,784) = 55.579, p \< 0.0001, but drinking was independent of prior trace, F(14,784) = 0.697, p = 0.778, and drug treatment, F(28,784) = 0.999, p = 0.468 ([Table 1](#tbl0005){ref-type="table"}C).

3.2. Experiment 2 with 4 conditioning trials {#sec0100}
--------------------------------------------

### 3.2.1. Pre-conditioning---baseline licking {#sec0105}

There were no effects of drug, F(2,63) = 0.996, p = 0.375, or trace condition-to-be, F(1, 63) = 1.868, p = 0.177, on latencies to start drinking on the final pre-conditioning day. This shows that the rats' drinking was well-matched prior to any conditioning. An ANOVA performed on the number of licks made over the 15-min session showed the expected main effect of min, because the rats drank more at the beginning of the session, F(14, 882) = 103.964, p \< 0.001. However, drinking over the session was not moderated by drug, F(28, 882) = 0.748, p = 0.825, or trace condition-to-be, F(14,882) = 1.251, p = 0.232 (data not shown).

### 3.2.2. Reshaping---contextual conditioning {#sec0110}

On the day following conditioning there was no evidence of any effect of drug or trace condition on drinking at the start of the session ([Fig. 2](#fig0010){ref-type="fig"}A). There was no difference in the drink latencies by drug, F(2,63) = 0.392, p = 0.678, or trace, F(1,63) = 0.732, p = 0.395, and there was no interaction between drug and trace, F(2,63) = 0.725, p = 0.488. The number of licks declined over the course of the 15-min session. Statistically, there was a main effect of min, F(14,882) = 77.385, p \< 0.001. However, the pattern of drinking over time was not influenced by drug, F(28,882) = 0.761, p = 0.810, or trace, F(14,882) = 1.396, p = 0.148 ([Table 2](#tbl0010){ref-type="table"}A).

### 3.2.3. CER test---noise CS {#sec0115}

There was a main effect of trace on the suppression ratio, F(1,63) = 43.625, p \< 0.001. As expected, rats conditioned with a 30 s trace interval were less suppressed than rats conditioned with a 3 s trace interval ([Fig. 2](#fig0010){ref-type="fig"}B). However, there was no effect of drug, either overall, F(2,63) = 1.198, p = 0.309, or in interaction with trace, F(2,63) = 2.275, p = 0.111. An ANOVA done to analyse the licks measure showed a main effect of min, F(14,882) = 34.495, p \< 0.001. Animals initially drank less, reflecting fear conditioning to the noise CS, but drinking later peaked and then dropped over the course of the 15 min session. There was both an overall effect of trace, F(1,63) = 7.228, p = 0.009, and an interaction between trace and min, F(14,882) = 6.779, p \< 0.001, as the difference between the 3-s and 30-s conditioned groups dropped over the course of the session ([Table 2](#tbl0010){ref-type="table"}B). Moreover, the interaction between drug and min was significant in the linear trend, F(2,63) = 4.252, p = 0.019, as was the three-way interaction, F(2,63) = 3.532, p = 0.035. ANOVA restricted to min 1 drinking showed a main effect of drug, F(2,63) = 4.832, p = 0.011, as well as the expected effect of trace, F(1,63) = 39.843, p = 0.001([Fig. 2](#fig0010){ref-type="fig"}C). The main effect of drug seen in min 1 arose because rats previously conditioned under 0.8 mg/kg SKF81297 drank more than those conditioned under 0.4 mg/kg SKF, p = 0.003. However neither of the groups conditioned under SKF81297 was significantly different from saline, smallest p = 0.064, for the 0.8 mg/kg group.

### 3.2.4. CER test---flashing lights background {#sec0120}

There was no difference in the suppression ratios by trace, F(1,63) = 1.258, p = 0.266, or the drug condition, F(2,63) = 0.496, p = 0.611, and there was no interaction between drug and trace, F(2,63) = 1.713, p = 0.188 ([Fig. 2](#fig0010){ref-type="fig"}D). On the licks measure, ANOVA showed the expected main effect of min, F(14,882) = 104.715, p \< 0.001. There were no interactions between min and trace, F(14,882) = 1.144, p = 0.315, or between min and drug, F(28,882) = 0.821, p = 0.731. The three-way interaction was significant, F(28,882) = 1.646, p = 0.019. Inspection of the means (shown in [Table 2](#tbl0010){ref-type="table"}C) suggests that this may have arisen because of a relatively steeper fall off in drinking in rats conditioned under SKF81297 at the 3-s ISI (compared to their respective saline controls), combined with less of a drop in rats conditioned under SKF81297 at the 30-s ISI (compared to their respective saline controls). However, the three-way interaction was significant in the quadratic rather than the linear trend, F(2.63) = 4.112, p = 0.021, and ANOVA restricted to min 1 showed no effect of drug, both Fs \< 1.

3.3. Locomotor activity {#sec0125}
-----------------------

The groups were initially well-matched in that in the 30 min preceding any injection there were no differences by drug condition-to-be, maximum F(4,38) = 2.033, p = 0.109, for the interaction with blocks. Then over the next 60 min, systemic administration of SKF81297 increased activity at both doses compared to saline starting 10 min after injection and lasting for the further 50 min test duration ([Fig. 3](#fig0015){ref-type="fig"}). There was an overall effect of drug, F(2,19) = 9.899, p = 0.001, because rats treated with 0.8 mg/kg SKF81297 were more active than those treated with 0.4 mg/kg (p = 0.006) or saline (p \< 0.001). The activity of rats treated with 0.4 mg/kg SKF81297 was not significantly different from that seen in the saline-injected controls (p = 0.251). There was an interaction between blocks and drug, F(10,95) = 5.310, p \< 0.001. Follow up analyses showed that this arose because although there was no difference by drug dose in the first 10-min block after injection, F(2,19) = 2.043, p = 0.157, there was an effect of drug in all subsequent 10 min blocks, minimum F(2,19) = 5.832, p = 0.011. Further post hocs confirmed that in blocks 5--9, there was a significant difference between the saline and the 0.8 mg/kg SKF81297-treated rats (p = 0.003 in block 5 and p \< 0.001 in block 9). The difference between the saline and 0.4 mg/kg SKF81297-treated rats did not reach significance in any block, though it was marginal in block 5 (p=0.059) and block 6 (p = 0.070).

4. Discussion {#sec0130}
=============

Trace-dependent conditioning was clearly shown in the present experiments in that while conditioning was relatively strong at the 3-s ISI, it was attenuated at the 30-s ISI. This was shown after two (Experiment 1) or four (Experiment 2) conditioning trials conducted in what was otherwise -- as far as possible -- the same CER procedure. Contrary to prediction, in neither experiment was there any indication that trace conditioning was attenuated by treatment with 0.4 or 0.8 mg/kg SKF81297.

The expected effect of increased LMA under SKF81297 provides a positive control for the effectiveness of this particular batch of drug ([@bib0175]). Neither was SKF81297 completely without effect in the trace conditioning procedure in that there was some evidence for reduced conditioning (measured as relatively increased min 1 licking) under 0.8 mg/kg SKF81297, seen in Experiment 2 which was conducted with an increased number of conditioning trials. There were also some indications that treatment with SKF81297 moderated (the expression of) contextual conditioning as measured in the pattern of drinking seen in the experimental boxes at reshaping in Experiment 1 or during the light test in Experiment 2. This latter effect is broadly consistent with the results seen after localised micro-infusion of SKF81297 in the anterior cingulate part of the mPFC. However, with the more localised administration and the standard two conditioning trials there was evidence for overall increased conditioning to the experimental background ([@bib0170]). In the present study, the observed effect was not so systematic. Moreover, there was no effect on suppression to the light background in either direction in Experiment 1 of the present study which used 2 conditioning trials.

With respect to the primary objective of the study, to assess effects on trace conditioning, there was no evidence for any reduction in trace conditioning after D1 receptor stimulation in the CER procedure used in the present study. This result is inconsistent with the effects of 0.4 and 0.8 mg/kg SKF81297 in appetitive trace conditioning ([@bib0165]). This discrepancy raises the possibility that appetitive versus aversive motivation of the trace conditioning task, in other words the nature of the US, is an important determinant of the susceptibility of trace conditioning to dopaminergic modulation ([@bib0010]). For example, particular combinations of stimuli do not start out equally effective in conditioning, to the extent that some CS-US relationships are learned more easily than others ([@bib0050]; [@bib0205]). However, with an appropriate adjustment to the ISI, trace-dependent conditioning is robustly demonstrated across a variety of conditioning preparations motivated by different appetitive and aversive USs ([@bib0010]; [@bib0085]; [@bib0105]; [@bib0140]; [@bib0165]). Therefore, with the right behavioural parameters, the effects of drugs and lesions on trace conditioning might in principle be expected to hold across different procedural variants. However, given the role of dopaminergic systems in the reinforcement mechanisms underlying conditioning ([@bib0005]; [@bib0035]; [@bib0045]; [@bib0090]; [@bib0095]; [@bib0160]; [@bib0195]), such stimulus-reinforcer interactions are likely to influence the susceptibility of associative learning to dopaminergic treatments, as has been found to be the case in latent inhibition procedures ([@bib0015]; [@bib0120]).

Ideally, we would have compared the effects of SKF81297 (and other DA agonists) using appetitive and aversive USs under directly comparable training conditions. Inevitably, over and above differences which may be attributable to task motivation per se, the task motivation in use has secondary effects on other aspects of the procedure, such as, for example, the number of conditioning trials. CER trace procedures only require two conditioning trials and -- as a legal requirement -- the number of foot shock US deliveries should be the minimum required to support the required level of associative learning. Appetitive conditioning takes place over many trials, up to over 100 in total ([@bib0010]; [@bib0165]), and we found that reliable demonstration of within day learning requires the use of 30 conditioning trials ([@bib0165]). Therefore the number of conditioning trials cannot in practice be equated between appetitive and aversive procedures. However, trace CER procedures have been conducted using 4 conditioning trials and a lower (0.5 mA) foot shock intensity ([@bib0140]) and -- adopting these procedures -- the effects of SKF81297 were further examined in Experiment 2 of the present study. However, within the constraints of the UK Animal Scientific Procedures Act 1986 Project Licence (PPL 40/3716), we were unable to establish any effect of SKF81297 on trace fear conditioning using the maximum number of conditioning trials permitted (4 trials conducted at half the standard foot shock intensity). Thus the lack of effect of SKF81297 was confirmed (in so far as we were able to test this) independent of the number and intensity of foot shocks.

Similarly, it is not in practice possible to match temporal aspects of appetitive and aversively motivated procedures because the ISIs suitable for optimal associative learning are different to begin with. We have routinely used a maximum ISI of 10 s in appetitive trace conditioning ([@bib0010]; [@bib0165]) compared with 30 s which has been found suitable to detect enhanced trace conditioning in the aversive procedure ([@bib0085], [@bib0125], [@bib0140]). The typical inter-trial-intervals are also rather longer for foot shock procedures. The fact that foot shocks are not given in quick succession allows the animals time to recover, and the required number of conditioning trials can be accommodated within a 15--25 min conditioning session ([@bib0010], [@bib0140]).

The response requirements of appetitively- and aversively-motivated procedures are also different. However, direct effects on response rate are excluded by the lack of any response requirement during conditioning when drug treatments are administered and the use of drug-free tests in the CER procedures of the present study. Moreover, drug effects on response rates are controlled for in appetitive trace conditioning procedures ([@bib0010]; [@bib0165]).

Because other DA agonists have previously been investigated using the same CER procedures, direct comparisons can be drawn with previously published studies. In the present study, we saw no evidence for enhanced trace conditioning as has been demonstrated after treatment with amphetamines in the CER procedure and at the 30-s trace interval used in the present experiments ([@bib0085], [@bib0140]). Albeit using a longer 60-s trace interval, the DA D4 agonist PD 168,077 was similarly without effect in a CER procedure ([@bib0125]). Taken together with the findings of the present experiments, this lack of effect with more selective receptor agents would seem to suggest that the overall profile of actions at different DA receptor sub-types and/or noradrenergically-mediated effects may mediate increased trace conditioning with an aversive US. Nonetheless procedural differences beyond motivation are likely to be critical. In a conditioned freezing procedure (the retention of) trace conditioning has been found to be impaired by DA D1 blockade in mPFC ([@bib0185]). Moreover, in contrast to the present study, [@bib0185] used a procedure designed to minimize contextual associations. We have routinely used an experimental background stimulus, which most likely increases the salience of context as well as providing a measure of contextual conditioning which can be tested in the same way as the CS ([@bib0085], [@bib0125], [@bib0140]).

We find that effects observed in appetitively-motivated trace conditioning do not simply reproduce in an aversively-motivated CER procedure, despite the fact that the CER procedure in use has previously shown sensitivity to dopaminergic manipulations and within the present experiments there were some signs of drug effects in measures of contextual conditioning, albeit not particularly systematic. The particular sensitivity of the appetitive task variant is consistent with the dominant view that DA mainly signals reward value ([@bib0200]). Even within this motivational system, the incentive value of the US can affect the profile of sensitivity to different DA receptor agents ([@bib0145]). Such differences will inevitably influence the dose-response function seen with individual compounds. Thus, we cannot exclude the possibility that different doses of SKF81297 would have been more effective in the present procedure, particularly given the results earlier obtained with mPFC infusions of SKF81297 ([@bib0165]) and SCH23390 ([@bib0185]).

We acknowledge that differences in the neural substrates of trace conditioning may relate to a multitude of procedural differences in addition to that of the reinforcers in use. Moreover, it is important to stress that such differences do not preclude the existence of neural substrates which mediate aspects of associative learning, such as trace conditioning, across paradigms. Nonetheless, discrepancies of the kind discussed above constrain the delineation of the neuropharmacological substrates of different facets of associative learning irrespective of task variant. Moreover, at the behavioural level the aim has been to establish general theoretical models of learning. The present data may be taken to suggest that different variants of the relevant learning theories may be needed to account for behaviour in tasks which are motivated aversively vs. appetitively, perhaps by formal inclusion of reinforcement sensitivity theory ([@bib0075], [@bib0070]).

Finally, given the imperative to refine experimental procedures ([@bib0190]), it is increasingly important to acknowledge that while appetitive procedures may be better from an animal welfare perspective, other inevitable differences -- likely motivational, but perhaps due to other methodological differences -- can change the conclusions to be drawn.
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![Effects on conditioning of the D1 receptor agonist SKF81297 at 0 (white columns), 0.4 (grey columns), and 0.8 (black columns) mg/kg in Experiment 1. The error bars show the standard error of the mean (n = 9-12/group). Tests were conducted drug-free after prior conditioning under drug conducted with two CS (noise) → US (1 mA shock) pairings, presented using either a 3-s or 30-s trace interval. A. Suppression to the experimental chambers: the level of contextual conditioning is expressed as mean latency to make the first lick (s). B. Conditioned suppression to the noise CS expressed as the mean suppression ratio. C. Conditioned suppression to the noise CS measured as the number of licks in the first min of test presentation. D. Conditioned suppression to the light background expressed as the mean suppression ratio.](gr1){#fig0005}

![Effects on conditioning of the D1 receptor agonist SKF81297 at 0 (white columns), 0.4 (grey columns), and 0.8 (black columns) mg/kg in Experiment 2. The error bars show the standard error of the mean (n = 10-12/group). Tests were conducted drug-free after prior conditioning under drug conducted with four CS (noise) → US (0.5 mA shock) pairings, presented using either a 3-s or 30-s trace interval. A. Suppression to the experimental chambers: the level of contextual conditioning is expressed as mean latency to make the first lick (s). B. Conditioned suppression to the noise CS expressed as mean suppression ratio. C. Conditioned suppression to the noise CS measured as the number of licks in the first min of test presentation. D. Conditioned suppression to the light background expressed as the mean suppression ratio.](gr2){#fig0010}

![Effect of systemic injections of SKF81297 on locomotor activity monitored for 60 min post injection (in blocks 5--9). For comparison, blocks 1--3 show habituation to the activity chambers over 30 min prior to injection. The error bars show the standard error of the mean (n = 7--8 rats per group). Asterisks indicate a significant difference as compared to saline: \*\*p \< 0.01; \*\*\*p \< 0.001.](gr3){#fig0015}

###### 

Licking behaviour over the 15 min sessions conducted at (A) reshaping, (B) the noise test and (C) the light test subsequent to treatment with the D1 receptor agonist SKF81297 (SKF) at 0, 0.4 and 0.8 mg/kg in Experiment 1. The table shows the mean number of licks made in each min ± the standard error of the mean. Tests were conducted drug-free after prior conditioning under SKF conducted with two CS (noise) → US (1 mA shock) pairings, presented using either a 3 s or 30 s trace interval.

Table 1

  --------------------------------------------------------------------------------------------------------------------------------
  A. Reshaping                                                                                                  
  -------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Drug           Sal                0.4\               0.8 SKF            Sal                0.4 SKF            0.8\
                                    SKF                                                                         SKF

  Min                                                                                                           

  1              202.750 ± 28.239   226.333 ± 24.863   211.000 ± 14.960   227.333 ± 16.627   208.500 ± 28.332   219.833 ± 20.827

  2              191.667 ± 20.791   207.000 ± 23.583   185.083 ± 17.194   169.333 ± 20.409   147.583 ± 19.085   163.667 ± 13.017

  3              163.083 ± 24.823   163.250 ± 14.691   155.333 ± 18.246   165.417 ± 21.496   167.667 ± 19.248   165.750 ± 16.945

  4              144.833 ± 25.087   129.250 ± 24.038   126.083 ± 21.704   154.917 ± 25.805   138.500 ± 19.927   141.833 ± 23.522

  5              121.333 ± 26.173   192.000 ± 19.897   116.333 ± 23.667   150.667 ± 26.655   127.333 ± 18.162   138.333 ± 13.796

  6              108.167 ± 27.579   137.583 ± 23.341   74.083 ± 20.020    166.750 ± 20.307   101.083 ± 19.558   148.000 ± 25.575

  7              132.667 ± 26.060   48.083 ± 12.852    121.500 ± 27.200   111.000 ± 25.445   120.000 ± 21.759   86.833 ± 16.878

  8              73.000 ± 23.584    54.167 ± 17.281    34.083 ± 12.277    83.667 ± 31.328    39.000 ± 15.216    87.000 ± 23.460

  9              66.917 ± 22.640    51.333 ± 18.054    47.500 ± 22.368    54.083 ± 20.973    63.833 ± 22.967    70.167 ± 28.729

  10             54.333 ± 21.091    32.750 ± 16.474    76.000 ± 23.739    64.083 ± 25.222    47.500 ± 13.996    40.667 ± 13.293

  11             62.000 ± 18.182    39.167 ± 13.439    12.333 ± 6.922     58.083 ± 23.147    21.583 ± 15.558    64.333 ± 23.410

  12             31.250 ± 21.437    26.667 ± 11.683    35.500 ± 15.895    30.500 ± 12.321    37.500 ± 17.502    54.833 ± 26.808

  13             39.250 ± 15.893    54.500 ± 25.917    26.000 ± 14.404    4.000 ± 3.645      23.917 ± 9.672     9.167 ± 5.396

  14             43.250 ± 20.096    12.417 ± 8.196     24.250 ± 12.437    16.500 ± 9.902     29.250 ± 12.464    27.917 ± 9.460

  15             42.417 ± 18.947    21.083 ± 15.0200   6.917 ± 6.826      12.500 ± 10.826    36.500 ± 8.609     51.917 ± 24.811
  --------------------------------------------------------------------------------------------------------------------------------

  ---------------------------------------------------------------------------------------------------------------------------------
  B. Noise test                                                                                                  
  --------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Drug            Sal                0.4\               0.8\               Sal                0.4 SKF            0.8\
                                     SKF                SKF                                                      SKF

  Min                                                                                                            

  1               20.667 ± 10.357    22.833 ± 12.567    56.583 ± 17.261    113.000 ± 25.138   130.333 ± 22.662   135.917 ± 24.542

  2               62.250 ± 26.232    70.083 ± 30.160    131.417 ± 27.623   161.000 ± 27.908   177.500 ± 8.593    207.167 ± 18.356

  3               93.167 ± 29.525    95.250 ± 29.600    150.000 ± 27.924   125.000 ± 19.271   159.583 ± 19.064   201.333 ± 19.806

  4               122.333 ± 30.279   101.500 ± 29.968   159.250 ± 28.873   167.167 ± 21.338   172.083 ± 13.284   144.917 ± 17.890

  5               111.250 ± 23.638   120.667 ± 32.568   177.750 ± 29.103   143.167 ± 26.263   114.417 ± 16.963   132.333 ± 27.089

  6               136.167 ± 22.669   113.000 ± 26.581   126.917 ± 20.100   85.750 ± 20.902    119.667 ± 21.371   134.833 ± 23.732

  7               111.167 ± 31.156   136.000 ± 25.675   124.667 ± 33.330   118.417 ± 21.351   55.583 ± 15.986    78.917 ± 21.097

  8               98.833 ± 28.623    124.750 ± 30.004   67.917 ± 23.152    124.167 ± 32.047   73.167 ± 19.793    103.250 ± 23.897

  9               117.667 ± 27.052   119.917 ± 26.733   116.917 ± 23.382   83.500 ± 24.872    105.500 ± 22.889   58.250 ± 22.364

  10              98.083 ± 27.136    127.167 ± 22.489   112.583 ± 26.639   70.417 ± 23.219    66.750 ± 13.694    51.417 ± 14.176

  11              63.667 ± 19.800    78.917 ± 28.806    46.083 ± 12.348    54.000 ± 20.892    29.167 ± 10.551    51.750 ± 21.620

  12              47.667 ± 21.513    89.500 ± 18.017    59.167 ± 18.739    33.750 ± 13.778    42.750 ± 13.979    17.500 ± 8.957

  13              70.000 ± 21.302    93.250 ± 20.240    62.000 ± 17.447    39.167 ± 19.459    25.750 ± 12.260    6.833 ± 4.846

  14              33.000 ± 13.375    45.083 ± 19.685    24.917 ± 12.321    51.250 ± 18.344    23.083 ± 11.206    27.167 ± 10.740

  15              41.250 ± 18.808    25.250 ± 13.811    18.750 ± 17.236    39.667 ± 17.751    35.333 ± 11.543    23.500 ± 11.020
  ---------------------------------------------------------------------------------------------------------------------------------

  C. Light test                                                                                                  
  --------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Drug            Sal                0.4 SKF            0.8 SKF            Sal                0.4 SKF            0.8 SKF
  Min                                                                                                            
  1               194.222 ± 36.321   219.400 ± 30.768   202.000 ± 29.447   222.600 ± 20.647   169.167 ± 28.812   212.545 ± 30.884
  2               188.000 ± 33.042   231.400 ± 20.749   179.900 ± 29.531   209.600 ± 14.811   192.833 ± 20.935   185.636 ± 25.594
  3               163.222 ± 32.100   233.700 ± 24.281   172.400 ± 23.865   185.200 ± 22.719   165.833 ± 19.908   166.364 ± 18.960
  4               164.333 ± 33.067   196.100 ± 21.714   162.600 ± 29.847   157.700 ± 20.087   138.500 ± 27.366   146.727 ± 32.314
  5               120.667 ± 33.384   131.500 ± 31.680   146.900 ± 22.000   153.300 ± 29.088   161.000 ± 18.989   153.091 ± 21.918
  6               107.000 ± 33.872   118.100 ± 27.533   123.900 ± 23.624   150.800 ± 26.368   124.000 ± 16.642   58.455 ± 18.216
  7               132.778 ± 33.168   117.300 ± 17.989   77.100 ± 31.154    148.200 ± 20.672   47.167 ± 18.253    67.455 ± 24.309
  8               126.000 ± 34.137   120.900 ± 26.409   75.300 ± 23.321    63.400 ± 28.637    85.833 ± 25.531    102.091 ± 26.361
  9               57.333 ± 24.927    49.400 ± 14.741    90.500 ± 25.976    68.100 ± 21.420    72.250 ± 23.573    91.545 ± 28.232
  10              47.111 ± 27.504    42.000 ± 19.693    47.600 ± 21.662    47.800 ± 23.056    39.833 ± 11.458    20.182 ± 9.571
  11              52.889 ± 20.402    25.400 ± 11.294    34.200 ± 16.817    40.100 ± 26.116    29.833 ± 11.971    37.909 ± 20.212
  12              60.667 ± 19.857    50.400 ± 27.414    13.900 ± 8.093     24.000 ± 16.277    17.750 ± 12.389    10.455 ± 8.388
  13              50.444 ± 25.868    18.600 ± 11.768    31.000 ± 14.844    43.200 ± 13.670    29.750 ± 13.005    37.636 ± 21.417
  14              27.333 ± 15.408    25.100 ± 17.642    28.000 ± 9.843     30.400 ± 12.317    17.667 ± 12.579    9.545 ± 5.808
  15              104.667 ± 34.721   31.800 ± 18.587    59.100 ± 15.959    61.400 ± 22.952    31.667 ± 14.159    42.364 ± 18.037

###### 

Licking behaviour over the 15 min sessions conducted at (A) reshaping, (B) the noise test and (C) the light test subsequent to treatment with the D1 receptor agonist SKF81297 (SKF) at 0, 0.4 and 0.8 mg/kg in Experiment 2. The table shows the mean number of licks made in each min ± the standard error of the mean. Tests were conducted drug-free after prior conditioning under drug conducted with four CS (noise) → US (0.5 mA shock) pairings, presented using either a 3 s or 30 s trace interval.

Table 2

  A. Reshaping                                                                                                  
  -------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Drug           Sal                0.4 SKF            0.8 SKF            Sal                0.4 SKF            0.8 SKF
  Min                                                                                                           
  1              219.400 ± 23.910   252.417 ± 13.516   232.000 ± 17.219   235.273 ± 15.936   200.333 ± 11.481   217.917 ± 17.219
  2              192.500 ± 21.749   194.250 ± 18.844   182.000 ± 20.006   180.545 ± 14.008   158.750 ± 16.068   194.333 ± 20.006
  3              126.300 ± 26.559   185.167 ± 21.536   168.000 ± 19.952   170.364 ± 14.154   165.083 ± 18.528   171.417 ± 19.952
  4              175.500 ± 21.127   129.000 ± 16.616   172.333 ± 24.838   197.091 ± 14.247   165.667 ± 22.494   145.083 ± 24.838
  5              124.000 ± 19.938   119.750 ± 19.353   157.333 ± 24.264   166.909 ± 29.597   137.083 ± 24.548   151.750 ± 24.264
  6              133.100 ± 22.213   163.917 ± 32.946   145.667 ± 24.398   116.545 ± 22.739   97.500 ± 23.501    116.083 ± 24.398
  7              104.200 ± 30.831   77.833 ± 13.092    110.333 ± 21.970   91.727 ± 26.255    48.417 ± 16.750    87.500 ± 21.970
  8              74.500 ± 20.281    83.250 ± 18.257    85.417 ± 20.083    121.000 ± 22.614   89.250 ± 23.736    81.333 ± 20.083
  9              68.400 ± 30.518    84.333 ± 25.449    44.250 ± 12.035    88.182 ± 17.317    60.417 ± 24.646    66.000 ± 12.035
  10             62.500 ± 25.892    47.000 ± 12.012    71.500 ± 26.719    63.455 ± 18.024    28.083 ± 10.413    36.000 ± 26.719
  11             40.000 ± 23.171    45.417 ± 15.109    31.417 ± 10.607    62.273 ± 22.757    33.833 ± 23.514    55.250 ± 10.607
  12             62.500 ± 26.705    39.333 ± 18.945    49.250 ± 14.171    31.182 ± 22.946    13.250 ± 12.533    58.917 ± 14.171
  13             27.400 ± 12.548    32.500 ± 21.329    15.000 ± 7.638     67.000 ± 26.248    29.000 ± 12.484    36.083 ± 7.638
  14             22.500 ± 11.592    28.917 ± 10.344    13.583 ± 6.689     16.364 ± 8.561     35.500 ± 12.203    20.167 ± 9.689
  15             14.700 ± 7.727     14.167 ± 7.569     15.167 ± 11.999    14.818 ± 8.396     38.417 ± 22.009    31.167 ± 11.999

  B. Noise test                                                                                                  
  --------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Drug            Sal                0.4 SKF            0.8 SKF            Sal                0.4 SKF            0.8 SKF
  Min                                                                                                            
  1               30.900 ± 22.637    18.583 ± 19.325    91.500 ± 26.411    155.182 ± 22.637   128.917 ± 19.325   180.333 ± 13.888
  2               64.200 ± 16.446    123.333 ± 15.752   131.583 ± 31.135   204.000 ± 16.446   178.750 ± 15.742   213.000 ± 15.521
  3               79.800 ± 20.543    146.583 ± 22.970   148.250 ± 22.569   189.455 ± 20.543   211.000 ± 22.970   183.833 ± 19.078
  4               114.100 ± 23.953   155.167 ± 25.985   157.167 ± 28.449   191.455 ± 23.953   156.917 ± 25.985   226.667 ± 14.498
  5               112.300 ± 19.552   114.250 ± 28.386   162.750 ± 23.111   159.545 ± 19.552   178.333 ± 28.386   151.333 ± 15.539
  6               85.900 ± 31.776    121.000 ± 15.562   155.417 ± 27.845   130.545 ± 31.776   136.167 ± 15.562   124.417 ± 22.413
  7               90.000 ± 30.834    125.250 ± 24.151   151.750 ± 29.676   91.727 ± 30.834    93.417 ± 24.151    99.083 ± 16.868
  8               97.800 ± 24.401    118.750 ± 28.424   122.333 ± 29.080   140.818 ± 24.401   93.833 ± 28.424    62.500 ± 17.506
  9               110.100 ± 30.670   50.750 ± 24.243    98.250 ± 17.777    142.091 ± 30.670   89.833 ± 24.243    78.167 ± 20.008
  10              69.600 ± 9.663     63.167 ± 19.572    101.333 ± 31.702   63.636 ± 9.663     81.750 ± 19.572    48.000 ± 22.186
  11              49.000 ± 17.780    52.083 ± 14.917    73.750 ± 19.429    67.727 ± 17.780    53.417 ± 14.917    55.750 ± 14.402
  12              112.500 ± 11.275   66.833 ± 10.637    37.667 ± 9.700     21.000 ± 11.275    60.833 ± 10.637    63.000 ± 24.069
  13              61.200 ± 9.478     29.667 ± 16.531    18.500 ± 6.336     42.364 ± 9.478     46.833 ± 16.531    27.083 ± 9.407
  14              46.800 ± 15.200    13.917 ± 14.663    23.750 ± 9.634     34.727 ± 45.200    37.667 ± 14.663    31.250 ± 12.688
  15              38.200 ± 19.402    12.167 ± 5.699     46.500 ± 20.493    22.182 ± 19.402    25.667 ± 5.699     28.250 ± 17.092

  C. Light test                                                                                                  
  --------------- ------------------ ------------------ ------------------ ------------------ ------------------ ------------------
  Drug            Sal                0.4 SKF            0.8 SKF            Sal                0.4 SKF            0.8 SKF
  Min                                                                                                            
  1               213.200 ± 22.637   241.833 ± 19.325   237.417 ± 19.107   246.091 ± 9.051    235.833 ± 14.389   232.833 ± 15.119
  2               215.700 ± 16.446   203.500 ± 15.742   202.583 ± 18.311   208.091 ± 14.130   193.250 ± 19.958   233.250 ± 12.792
  3               194.600 ± 20.543   182.667 ± 22.970   178.750 ± 24.148   237.909 ± 18.239   202.667 ± 13.380   232.417 ± 14.651
  4               152.900 ± 23.953   138.883 ± 25.985   196.250 ± 21.783   195.364 ± 28.447   182.833 ± 31.407   176.083 ± 24.513
  5               121.400 ± 19.552   129.167 ± 28.386   173.083 ± 23.324   196.727 ± 23.586   183.333 ± 28.771   172.417 ± 19.967
  6               106.000 ± 31.776   143.917 ± 15.562   112.833 ± 16.875   159.727 ± 19.284   146.417 ± 22.854   115.000 ± 23.029
  7               80.000 ± 30.834    114.167 ± 24.151   191.083 ± 25.129   168.364 ± 28.907   104.333 ± 23.833   111.000 ± 18.209
  8               61.000 ± 24.401    53.520 ± 28.424    87.917 ± 25.031    63.818 ± 24.287    119.833 ± 27.705   65.667 ± 20.280
  9               56.700 ± 30.670    83.167 ± 24.243    70.333 ± 19.932    64.364 ± 22.517    120.667 ± 24.911   81.750 ± 16.272
  10              27.400 ± 9.663     56.583 ± 19.572    31.667 ± 11.91     76.000 ± 18.875    57.917 ± 21.354    76.917 ± 25.204
  11              31.800 ± 17.780    33.500 ± 14.917    72.083 ± 16.419    32.182 ± 11.243    25.500 ± 9.953     39.833 ± 16.540
  12              20.500 ± 11.275    29.883 ± 10.637    13.083 ± 7.586     2.091 ± 2.091      29.333 ± 12.306    41.000 ± 11.101
  13              19.500 ± 9.478     35.417 ± 16.531    35.750 ± 16.417    19.636 ± 12.228    23.750 ± 10.798    27.000 ± 12.498
  14              15.200 ± 15.200    45.667 ± 14.663    20.083 ± 13.376    14.545 ± 8.545     48.083 ± 16.037    38.167 ± 9.898
  15              56.400 ± 19.402    8.500 ± 5.699      3.667 ± 2.802      2.727 ± 2.000      57.667 ± 25.104    47.667 ± 18.428
